EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic Impact of Ectopic Fat Deposition Within the Psoas Muscle in Patients with Stage IV Pancreatic Cancer Receiving Systemic Chemotherapy

İbrahim Çil iD, İlker Nihat Ökten iD, Zeynep Nihal Kazcı iD, Ayberk Bayramgil iD, Tuba Baydaş iD, Gözde Balkaya Aykut, Pembegül Yumuştutan, Aziz Batu, Yunus Emre Altintas iD, Sevde Nur Emir iD, Fatma Kulalı, Melike Özçelik iD

Journal of Clinical Medicine · 20.05.2026 · 15 (10) · 3936

DOI: 10.3390/jcm15103936 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 20.05.2026. Verfasst von İbrahim Çil und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Umraniye Training and Research Hospital, Istanbul 34764, Türkiye. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Computed tomography-based body composition parameters are emerging prognostic markers in pancreatic cancer. While sarcopenia and myosteatosis have been widely studied, the prognostic significance of ectopic fat deposition within the psoas muscle remains unclear. We aimed to evaluate the prognostic impact of the fat ratio within the psoas muscle (FRPM) in patients with stage IV pancreatic cancer receiving first-line systemic chemotherapy.

Methods

This retrospective cohort study included 99 patients with stage IV pancreatic cancer treated with first-line chemotherapy. Baseline CT images at the L3 level were analyzed, and FRPM was calculated as the proportion of intramuscular fat to total psoas muscle area. FRPM was analyzed primarily as a continuous variable. Exploratory low- and high-FRPM groups were defined using sex-specific medians for descriptive comparisons and Kaplan–Meier analyses. Overall survival (OS) and progression-free survival (PFS) were assessed using Kaplan–Meier and Cox regression analyses. Multivariable models were adjusted for age, sex, ECOG performance status, liver metastasis, and C-reactive protein (CRP).

Results

Among 99 patients, 48 were categorized as having low FRPM and 51 as having high FRPM based on exploratory sex-specific median-based groups. Higher FRPM correlated with older age and higher BMI and inversely correlated with psoas muscle size and PMI. Median OS was 9.76 months in the low-FRPM group versus 5.78 months in the high-FRPM group, and median PFS was 5.29 versus 3.68 months. In the main multivariable Cox model, higher FRPM was associated with worse OS when analyzed as a continuous variable and reported per 1-standard deviation increase (adjusted HR: 1.43, 95% CI: 1.08–1.91, p = 0.014). After additional adjustment for first-line treatment-regimen category, the association remained directionally consistent but did not retain conventional statistical significance (adjusted HR: 1.32, 95% CI: 0.99–1.77, p = 0.060).

Conclusions

Higher FRPM was associated with shorter OS and PFS in patients with stage IV pancreatic cancer receiving first-line systemic chemotherapy. These findings suggest that ectopic fat deposition within the psoas muscle may represent a potential CT-based muscle-quality marker associated with adverse prognosis. External validation and comparison with conventional adiposity parameters are required before clinical application.

Schlagwörter

Stichwörter der Autor:innen

body compositionmyosteatosispancreatic cancerprognostic biomarkerpsoas muscle

Autor:innen und Institutionen

  • Department of Medical Oncology, Umraniye Training and Research Hospital, Istanbul 34764, Türkiye.
  • Department of Medical Oncology, Göztepe Şehir Hospital, Istanbul Medeniyet University, Istanbul 34722, Türkiye.
  • Department of Radiology, Göztepe Şehir Hospital, Istanbul Medeniyet University, Istanbul 34722, Türkiye.
  • Department of Radiology, Umraniye Training and Research Hospital, Istanbul 34764, Türkiye.

ORCID-Profile: İbrahim Çil, İlker Nihat Ökten, Zeynep Nihal Kazcı, Ayberk Bayramgil, Tuba Baydaş, Yunus Emre Altintas, Sevde Nur Emir, Melike Özçelik

Zitieren

APA

Çil, İ., Ökten, İ. N., Kazcı, Z. N., Bayramgil, A., Baydaş, T., Balkaya Aykut, G., Yumuştutan, P., Batu, A., Altintas, Y. E., Emir, S. N., Kulalı, F., & Özçelik, M. (2026). Prognostic Impact of Ectopic Fat Deposition Within the Psoas Muscle in Patients with Stage IV Pancreatic Cancer Receiving Systemic Chemotherapy. Journal of Clinical Medicine, 15(10), 3936. https://doi.org/10.3390/jcm15103936

Vancouver

Çil İ, Ökten İN, Kazcı ZN, Bayramgil A, Baydaş T, Balkaya Aykut G, et al. Prognostic Impact of Ectopic Fat Deposition Within the Psoas Muscle in Patients with Stage IV Pancreatic Cancer Receiving Systemic Chemotherapy. Journal of Clinical Medicine. 2026;15(10):3936. doi:10.3390/jcm15103936

BibTeX
@article{il2026,
  author = {Çil, İbrahim and Ökten, İlker Nihat and Kazcı, Zeynep Nihal and Bayramgil, Ayberk and Baydaş, Tuba and Balkaya Aykut, Gözde and Yumuştutan, Pembegül and Batu, Aziz and Altintas, Yunus Emre and Emir, Sevde Nur and Kulalı, Fatma and Özçelik, Melike},
  title = {Prognostic Impact of Ectopic Fat Deposition Within the Psoas Muscle in Patients with Stage IV Pancreatic Cancer Receiving Systemic Chemotherapy},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {10},
  pages = {3936},
  doi = {10.3390/jcm15103936}
}
Kostenlos starten →